In winning the most prestigious award that can be bestowed onto a British company, we join a cohort of 226 exciting and innovative companies to have been recognized nationally for their outstanding achievement in business.
team is led by CEO, Herve , who has over 25 years’ experience in the pharmaceutical industry before establishing the company in 2016. Herve has said – “This award is a true testament to our strong global footprint and substantial year-on-year growth. By enabling our clients to define the right value strategy and the right price for their products, we are proud to contribute to improving health, one severe disease at a time.”
Since our inception, our sales have grown by >60% year-on-year, with international sales consistently accounting for ~75% of our total revenue. Our projects are almost exclusively multinational; in the past year alone, we have conducted projects within European markets (France, Germany, Italy, Spain, Nordics, Baltics, Turkey), the US, Canada, Asia (China, Japan, India, Vietnam), Russia and the GCC (Saudi Arabia, Qatar, UAE, Kuwait).
Our key strengths are -
- In-depth knowledge of healthcare systems – both in terms of their current state and possible future evolutions, with a focus on pharmaceutical pricing and access
- Therapy area expertise with a high level of proficiency in rare disease and advanced therapy medicinal products (ATMPs), neurology, immunology, and
- Methodological expertise with mastery of key insights and modelling techniques, both qualitative and
- Active engagement in our community through thought leadership pieces and conferences
We are striving to build a truly diverse, international team – with eight languages across 11 employees at present, we don’t think we are doing a bad job! We also work with a network of trusted local partners across the globe to ensure we can provide the most relevant and actionable insights and recommendations.
Pippa Macnair, Associate Director, says “I see our approach as a truly unique offering, allowing us to combine the deep in-market expertise of local consultants with our best-in-class strategy development tools”.
This is an incredible recognition of team and of the trust our clients and partners place on us every day. 2022 is set to be a huge year of growth for us, as we are truly excited to welcome on board highly talented individuals and continue to work on exciting strategic projects at the cutting edge of science.
If you would like to find out more about how we can help optimize your market access & pricing strategy, please contact Herve at firstname.lastname@example.org.
If you are interested in joining our amazing team, please contact Pippa at email@example.com.